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Reduced right ventricular function on
cardiovascular magnetic resonance imaging
is associated with uteroplacental
impairment in tetralogy of Fallot
Anne S. Siegmund1, Tineke P. Willems2, Petronella G. Pieper1, Caterina M. Bilardo3, Thomas M. Gorter1,
Berto J. Bouma4, Monique R. M. Jongbloed5, Gertjan Tj. Sieswerda6, Jolien W. Roos-Hesselink7, Arie P. J. van Dijk8,
Dirk J. van Veldhuisen1 and Michael G. Dickinson1*
Abstract
Background: Maternal right ventricular (RV) dysfunction (measured by echocardiography) is associated with
impaired uteroplacental circulation, however echocardiography has important limitations in the assessment of RV
function. We therefore aimed to investigate the association of pre-pregnancy RV and left ventricular (LV) function
measured by cardiovascular magnetic resonance with uteroplacental Doppler flow parameters in pregnant women
with repaired Tetralogy of Fallot (ToF).
Methods: Women with repaired ToF were examined, who had been enrolled in a prospective multicenter study of
pregnant women with congenital heart disease. Clinical data and CMR evaluation before pregnancy were
compared with uteroplacental Doppler parameters at 20 and 32 weeks gestation. In particular, pulsatility index (PI)
of uterine and umbilical artery were studied.
Results: We studied 31 women; mean age 30 years, operated at early age. Univariable analyses showed that
reduced RV ejection fraction (RVEF; P = 0.037 and P = 0.001), higher RV end-systolic volume (P = 0.004) and higher LV
end-diastolic and end-systolic volume (P = 0.001 and P = 0.003, respectively) were associated with higher uterine or
umbilical artery PI. With multivariable analyses (corrected for maternal age and body mass index), reduced RVEF
before pregnancy remained associated with higher umbilical artery PI at 32 weeks (P = 0.002). RVEF was lower in
women with high PI compared to women with normal PI during pregnancy (44% vs. 53%, p = 0.022). LV ejection
fraction was not associated with uterine or umbilical artery PI.
Conclusions: Reduced RV function before pregnancy is associated with abnormal uteroplacental Doppler flow
parameters. It could be postulated that reduced RV function on pre-pregnancy CMR (≤2 years) is a predisposing
factor for impaired placental function in women with repaired ToF.
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Introduction
Evidence that maternal cardiac function influences uter-
oplacental circulation, and consequently pregnancy out-
come, is increasing [1–3]. In normal pregnancy, the
uteroplacental circulation is a “low-resistance vessel-
bed” [4], and uteroplacental Doppler flow investigation,
in particular the Pulsatility Index (PI) of the uterine and
umbilical arteries, provides insight into the placentation
process. Abnormalities in placentation results in a high
uteroplacental vascular resistance, reflected by abnormal
uteroplacental Doppler patterns (high PI). These abnor-
mal patterns are, in turn, associated with adverse mater-
nal and neonatal outcome [5, 6]. To improve pregnancy
counseling and monitoring in women with heart disease,
more insight in the relationship between the heart and
uteroplacental circulation is needed.
Interestingly, the number of studies that have exam-
ined placental function in patients with heart disease
and failure is very limited, when compared to the large
number of available data on organ dysfunction in pa-
tients with heart failure [7–11]. Indeed, in heart failure,
specific effects on the kidney [7–9], the liver [10], and
also the brain [11] have been reported. It could be hy-
pothesized that during pregnancy in women with cardiac
dysfunction or failure (for example women with repaired
tetralogy of Fallot (ToF), the placenta also undergoes
changes that can be (partly) seen as organ dysfunction.
It is generally accepted that organ dysfunction in pa-
tients with heart failure is mainly attributed to impaired
perfusion (forward failure) due to decreased cardiac out-
put (CO). However, venous congestion (backward fail-
ure) is also an important factor in organ dysfunction, as
clearly shown in the kidney and liver [7, 9, 10]. The pla-
centa can be seen as a temporary fetomaternal vascular
organ. Therefore, similar hemodynamic interactions be-
tween the heart and the placenta may be present. Our
previous studies in pregnant women with congenital
heart diseases showed a consistent association between
impaired right ventricular (RV) parameters and impaired
uteroplacental Doppler parameters [1, 12–14]. However,
these studies only focused on echocardiography pa-
rameters, which has known limitations, particularly in
the assessment of RV function. Furthermore, CO
measurements were not available and thus investiga-
tion of forward function was limited. Today, cardio-
vascular magnetic resonance (CMR) is the gold
standard for the assessment of RV volume and func-
tion [15]. CMR evaluation could provide more insight
in how RV function may influence uteroplacental cir-
culation. In the present study, we therefore aimed to
investigate the relationship of (pre-pregnancy) RV and
left ventricular (LV) function measured by CMR with
uteroplacental Doppler flow parameters during preg-
nancy in women with repaired ToF.
Methods
Study design and patient selection
All women in the present study were pregnant women
with repaired ToF who had been enrolled in the pro-
spective multicenter observational cohort ZAHARA II
or ZAHARA III study (2008–2015) [1, 14, 16]. In the
present (sub-) study, women who also underwent
CMR ≤ 2 years before their pregnancy were identified.
Pregnant women with repaired ToF, aged ≥18 years, pre-
senting in one of the participating centers ≤20 weeks
gestation were thus eligible for enrollment in the current
study.
Pre-pregnancy baseline data were collected from the
medical records. These included maternal age, additional
heart defects, cardiovascular history, pre-pregnancy car-
diac status (including New York Heart Association
(NYHA) functional class, modified World Health
Organization (WHO) risk class before pregnancy (risk
classification of maternal cardiovascular risk during
pregnancy [17]), Electrocardiogram (ECG), laboratory
results and echocardiographic recordings) and relevant
medication use. Women were excluded if they had a sur-
gical or transcatheter pulmonary valve intervention be-
tween the CMR study and their pregnancy. The study
protocol was approved by the Research Ethics Commit-
tee of the participating centers and all participating
women gave written informed consent.
Uteroplacental Doppler flow measurements
Routine evaluation of uteroplacental circulation in sec-
ond and third trimester was performed at 20 and 32
weeks gestation by uteroplacental Doppler flow mea-
surements consisting the PI of the uterine and umbilical
arteries, according to the guidelines of the International
Society of Ultrasound in Obstetrics and Gynaecology
[18, 19]. Uterine or umbilical artery PI was considered
high if the value exceeded the 95th percentile reference
values according to gestational age in healthy pregnant
women [20, 21].
CMR imaging
CMR protocols for the acquisition of cardiac volumes,
functional parameters and flow have been previously
published by our group [22, 23]. In brief, CMR assess-
ments were performed using a 1.5 T CMR scanner.
ECG-triggered cine loop images were obtained during
end-expiratory breath holds, using a retrospectively
gated balanced steady-state free precession sequence.
The four-chamber view was used for long-axes slices
and short-axis were acquired covering both ventricles
from base to apex. A 2-D gradient echo Fast Low Angle
Shot (FLASH) was used to perform two dimensional vel-
ocity encoded CMR flow measurements, perpendicular
and ± 1.5 cm cranial to the pulmonary and aortic valve,
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and were acquired during normal respiration with retro-
spective cardiac gating.
CMR analysis
All CMR studies were analyzed offline using dedicated
software (QMass 7.6, Medis, Leiden, The Netherlands)
to quantify ventricular function, volume and mass and
to analyze pulmonary artery and aortic flow. The assess-
ments were performed by one observer (A.S.S.) and
reviewed by another observer (T.M.G.) In case of dis-
agreement, CMR studies were also reviewed by a certi-
fied level 3 trained cardiovascular radiologist (T.P.W.).
Endo - and epicardial borders of the LV and RV were
manually traced in end-diastolic and end-systolic phases.
On the most basal slice, both atria, the aorta and the
pulmonary artery were excluded. The RV outflow tract
was included until the pulmonary valve. The papillary
muscle and trabeculae were excluded from ventricular
volumes, by using semi-automatic threshold-based seg-
mentation software (MassK Mode®, Medis, Leiden, The
Netherlands) [24]. End-diastolic and end-systolic vol-
umes were automatically calculated by the summation of
slices multiplied by slice thickness method. Stroke vol-
ume, ejection fraction (EF), ventricular mass and RV/LV
volume ratio were calculated using standard formulas.
Pulmonary artery and aortic flow were analyzed using
Qflow 5.6 (Medis, Leiden, The Netherlands). Pulmonary
and aortic contours were generated semi-automatically
on the standard magnitude images, and thereafter manu-
ally adjusted for each phase image. Forward and back-
ward flow of the aortic and pulmonary valve were
measured and used to calculate CO and regurgitation
fraction using standard formulas. All absolute volumes
and masses were indexed for body surface area mea-
sured at the time of CMR. LV and RV dysfunction were
defined as EF < 50 and < 45%, respectively [25, 26].
Statistical analysis
Continuous variables with normal distribution are pre-
sented as mean with standard deviation (±SD), non-
normally distributed data as median with interquartile
ranges [Q1-Q3], dichotomous variables as absolute num-
bers with percentages. Correlations were calculated
using Pearson’s product moment if variables were con-
tinuous and Spearman’s rank–order correlation if either
of the variables was ordinal. For the primary endpoint,
univariable and multivariable linear regression were used
to associate baseline characteristics (age, body mass
index (BMI) and parity) and CMR parameters (RV and
LV function, volume and mass and RV/LV volume ratio)
with uterine and umbilical PI at 20 and 32 weeks gesta-
tion. For multivariable analysis, known predisposing fac-
tors for poor placentation (age and BMI [27]) and RV
function (RVEF) based on our previous results were
selected [1, 12–14]. To maintain model validity, variables
were kept to a maximum of 3 due to the small study
sample. Multivariable Lasso regression with penalized
selection of variables was performed to identify the most
parsimonious model and to confirm results of the uni-
variable analyses. Logistic regression analyses were per-
formed to associate baseline CMR parameters with high
PI of uterine or umbilical artery during pregnancy (indi-
cative for abnormal placentation). High or normal PI
during pregnancy was established in women with
complete follow-up data available of uterine and umbil-
ical artery PI at 20 and 32 weeks gestation. Comparison
of continuous variables between groups (high vs. normal
PI) was performed with the Student t-test or Mann-
Whitney U test, depending on distribution.
For internal validation, because of the time gap be-
tween CMR evaluation and pregnancy, linear univariable
regression were used to associate echocardiographic pa-
rameters of ventricular function (LVEF, tricuspid annu-
lar plane systolic excursion (TAPSE), S′) and chamber
dimensions during pregnancy (at 20 and 32 weeks) with
uteroplacental Doppler flow parameters. A p-value <
0.05 was considered statistically significant. Statistical
analyses were performed using the SPSS version 23.0
software package (Statistical Package for the Social Sci-
ences, International Business Machines, Inc., Armonk,
New York, USA) and STATA software package (version
13, Stata Corporation, College Station, Texas, USA).
Results
Pre-pregnancy characteristics
In the ZAHARA II and III study 66 repaired ToF
women were included. For the present study, women
were excluded because of miscarriage (n = 3), no CMR
evaluation available because of a pacemaker (n = 3) or
no CMR evaluation available within 2 years before preg-
nancy (n = 29), resulting in a total study population of 31
repaired ToF women (median time between the CMR
evaluation and date of conception was 8 [3–14]
months).
Pre-pregnancy characteristics are presented in Table 1.
One woman had a history of arrhythmia and one woman
had a history of heart failure. None of the women had
hypertension before pregnancy. Because of atrial tachy-
arrhythmia or reduced LV function, five (16.1%) women
were on beta-blocker therapy before pregnancy. One
woman was on angiotensin converting enzyme inhibitor
therapy and no diuretics were used. Ventricular volume
and function data are outlined in Table 2.
Relationship between pre-pregnancy CMR parameters
and uteroplacental circulation
Median time between pre-pregnancy CMR evaluation
and uteroplacental flow measurements at 20 weeks and
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32 weeks gestation were 12 [7–19] months and 15 [10–
23] months, respectively. Uteroplacental flow measure-
ments (PI) were available in 26 (83.9%) ToF women at
20 weeks and in 28 (90.3%) ToF women at 32 weeks ges-
tation. Univariable and multivariable associations of pre-
pregnancy CMR parameters, uterine artery PI at 20
weeks and umbilical artery PI at 32 weeks gestation of
ToF women are reported in Tables 3 and 4. Reduced
RVEF, higher indexed LV end diastolic volume (EDV)
and LV end systolic volume (ESV) were associated with
impaired uterine artery PI at 20 weeks with univariable
analyses (P = 0.037, P = 0.001 and P = 0.003, respectively).
Higher maternal age, reduced RV EF and higher indexed
RV ESV were associated with impaired umbilical artery
PI at 32 weeks with univariable analyses (P = 0.037, P =
0.001 and P = 0.004, respectively). A negative correlation
was found between RVEF and indexed LV ESV (P =
0.016). No correlation was found between RVEF and
pulmonary regurgitation fraction.
With multivariable analyses (corrected for age and
BMI), reduced RVEF before pregnancy remained signifi-
cantly associated with higher umbilical artery PI at 32
weeks gestation. Lasso regression analysis including all
parameters (as shown in Tables 3 and 4) at 20 weeks se-
lected RVEF and indexed LV EDV and at 32 weeks se-
lected age, BMI, RVEF and RVESVI in the
aforementioned models. The associations between
RVEF, LVEF and uteroplacental flow (PI) are shown in
Fig. 1. High PI (at 20 or 32 weeks) was reported in 6
(30.0%) of the 20 women with complete evaluation avail-
able of uterine and umbilical PI during pregnancy. Only
RVEF was associated with high PI values (odds ratio =
0.85, P = 0.045). As shown in Fig. 1, RVEF was signifi-
cantly lower in women with high PI values, compared to
women with normal PI during pregnancy (44% vs. 53%,
p = 0.022).
Univariable analyses of echocardiographic parameters
during pregnancy with uteroplacental flow showed that
reduced RV function (S′), higher index RV diameter
(basal) and outflow tract dimension at 20 weeks were as-
sociated with impaired umbilical artery PI at 32 weeks
(P = 0.045, P = 0.047 and P = 0.008, respectively). For in-
ternal validation, correlation was assessed between pre-
conception CMR and echocardiography data during
pregnancy. A correlation was found between pre-
pregnancy RV volume measured by CMR (RV EDV) and
RV echocardiographic dimensions (basal diameter and
outflow tract) at 20 weeks gestation (Pearson = 0.794,
P < 0.001 and Pearson = 0.624, P = 0.013, respectively). A
trend was shown in the correlation between pre-
pregnancy RVEF and RV S′ at 20 weeks gestation (Pear-
son = 0.425, P = 0.070).
Discussion
The main finding of the present CMR study is that a re-
duced RV function before pregnancy is associated with
impaired uteroplacental Doppler parameters during
pregnancy in women with repaired ToF. These findings
suggest that impaired RV function might be a predispos-
ing factor for poor placental function, which is known to
be associated with adverse maternal and neonatal
outcome.
Table 1 Baseline characteristics (prior to pregnancy)
Total n = 31
Maternal age at conception (years) 30.0 ± 4.8








Age complete ToF repair 2 [1–5 years]
Type of ToF repair
Infundibular patch / commissurotomy 13 (41.9%)
Transannular patch 12 (38.7%)
RV-pulmonary artery conduit 2 (6.5%)
Other 4 (12.9%)
Pulmonary valve replacement 8 (25.8%)
Data is reported as mean ± SD, median [interquartile range] or n (%).aRisk
classification of maternal cardiovascular risk during pregnancy [17]. BMI body
mass index, NYHA New York Heart Association, RV right ventricle, ToF Tetralogy
of Fallot, WHO World Health Organization
Table 2 Pre-pregnancy cardiac magnetic resonance imaging
Total n = 31
RV mass index (g/m2) 30.5 ± 7.4
RV end-diastolic volume index (ml/m2) 119.0 ± 32.5
RV end-systolic volume index (ml/m2) 61.9 ± 23.0
RV cardiac output (L/min) 4.7 ± 0.9
RV ejection fraction (%) 49.0 ± 7.7
RV dysfunction (EF < 45%) 9 (29.0%)
RV/LV volume ratio 1.5 ± 0.6
LV mass index (g/m2) 42.2 ± 11.1
LV end-diastolic volume index (ml/m2) 79.6 ± 18.1
LV end-systolic volume index (ml/m2) 34.1 ± 11.7
LV cardiac output (L/min) 4.8 ± 0.8
LV ejection fraction (%) 57.8 ± 5.9
LV dysfunction (EF < 50%) 2 (6.5)
Pulmonary regurgitation fraction (%) 24.7 ± 19.3
Data is reported as mean ± SD or n (%). EF ejection fraction, LV left ventricle,
RV right ventricle
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Table 3 Univariable and multivariable regression analysis pre-pregnancy CMR parameters and uterine artery PI at 20 weeks gestation
N Beta (95% CI) P-value
Univariable
Age at conception 26 −0.007 (− 0.044–0.030) 0.687
BMI (kg/m2) 26 − 0.018 (− 0.053–0.017) 0.299
Parity 26 −0.048 (− 0.370–0.284) 0.788
RV mass index (g/m2) 26 0.002 (− 0.019–0.023) 0.874
RV EDVI (mL/m2) 26 0.004 (− 0.003–0.010) 0.270
RV ESVI (mL/m2) 26 0.008 (− 0.001–0.016) 0.064
RV cardiac output (L/min) 25 −0.026 (− 0.167–0.115) 0.707
RVEF (%) 26 − 0.021 (− 0.041 – − 0.001) 0.037
RV/LV volume ratio 26 − 0.267 (− 0.730–0.197) 0.247
LV mass index (g/m2) 26 0.006 (− 0.013–0.025) 0.509
LV EDVI (mL/m2) 26 0.015 (0.007–0.023) 0.001
LV ESVI (mL/m2) 26 0.018 (0.007–0.030) 0.003
LV cardiac output (L/min) 23 − 0.047 (− 0.277–0.182) 0.671
LVEF (%) 26 − 0.019 (− 0.043–0.006) 0.126
Multivariable
RVEF adjusted for age 26 −0.008 (− 0.042 – − 0.001) 0.040
RVEF adjusted for age and BMI 26 − 0.020 (− 0.041–0.001) 0.057
BMI body mass index, LV left ventricle, LVEF left ventricular ejection fraction, LV EDVI indexed left ventricular end diastolic volume, LV ESVI indexed left ventricular
end systolic volume, RV right ventricle, RVEF right ventricular ejection fraction, RV EDVI indexed right ventricular end diastolic volume, RV ESVI indexed right
ventricular end systolic volume
Table 4 Univariable and multivariable regression analysis pre-pregnancy CMR parameters and umbilical artery PI at 32 weeks
gestation
N Beta (95% CI) P-value
Univariable
Age at conception 28 0.015 (0.001–0.030) 0.037
BMI (kg/m2) 28 −0.014 (− 0.030–0.001) 0.071
Parity 28 0.045 (− 0.103–0.194) 0.536
RV mass index (g/m2) 28 0.002 (− 0.008–0.012) 0.655
RV EDVI (mL/m2) 28 0.002 (0.000–0.005) 0.057
RV ESVI (mL/m2) 28 0.005 (0.002–0.008) 0.004
RV cardiac output (L/min) 27 −0.029 (− 0.092–0.034) 0.347
RVEF (%) 28 − 0.015 (− 0.023 – − 0.006) 0.001
RV/LV ratio 28 0.079 (− 0.051–0.208) 0.222
LV mass index (g/m2) 28 0.001 (− 0.006–0.008) 0.752
LV EDVI (mL/m2) 28 0.001 (− 0.004–0.005) 0.778
LV ESVI (mL/m2) 28 0.002 (− 0.005–0.008) 0.582
LV cardiac output (L/min) 24 −0.025 (− 0.116–0.067) 0.581
LVEF (%) 28 − 0.006 (− 0.019–0.006) 0.305
Multivariable
RVEF adjusted for age 28 −0.014 (− 0.021 – − 0.006) 0.001
RVEF adjusted for age and BMI 28 − 0.013 (− 0.020 – − 0.005) 0.002
BMI body mass index, LV left ventricle, LVEF left ventricular ejection fraction, LV EDVi indexed left ventricular end diastolic volume, LV ESVi indexed left ventricular
end systolic volume, RV right ventricle, RVEF right ventricular ejection fraction, RV EDVI indexed right ventricular end diastolic volume, RV ESVI indexed right
ventricular end systolic volume
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The current study combining CMR with PI confirms
our previous findings that pre-existing reduced RV func-
tion is associated with impaired uteroplacental circula-
tion [1, 12–14]. In our previous echocardiographic
studies, we were limited in the assessment of RV func-
tion and CO measurements due to the specific modality.
In the present study, we used CMR, i.e. the accepted
gold standard assessment of cardiac function resulting in
more robust information about RV and LV function.
To the extent of our knowledge, this is the first study
to investigate both reduced CO and RV dysfunction in
relation to abnormal uteroplacental Doppler flow param-
eters. Our findings suggest that pre-existing impaired
RV function, rather than impaired LV function, has a
negative effect on placentation. Venous congestion could
play a central role in this effect. This has previously been
shown for other organs in patients with heart failure. In-
deed, in such patients, it is well known that kidney and
liver failure are associated with impaired organ perfu-
sion. Interestingly, venous congestion seems to be a
more important hemodynamic determinant for deterior-
ation of renal and liver function than reduced perfusion
[7, 10]. Furthermore, RV dysfunction is a strong pre-
dictor of renal impairment in patients with decompen-
sated heart failure [28, 29]. The same could possibly be
true for impaired placental circulation. Evidence that RV
dysfunction plays a prominent role in placental develop-
ment and uteroplacental flow regulation is increasing.
The question that remains is whether RV dysfunction is
a direct cause of abnormal uteroplacental circulation pa-
rameters, and if so, what is the underlying pathophysio-
logical mechanism. Could it be that RV dysfunction
leads to venous congestion resulting in defective placen-
tation or is the RV unable to increase CO during preg-
nancy due to worse functional reserve? To answer this
question, other conditions could possibly give us some
insight. For instance, there is increasing evidence that
venous congestion plays a role in pre-eclampsia. Despite
widespread consensus that pre-eclampsia is a predomin-
ant placental disorder (associated with abnormal utero-
placental flow patterns), maladaptation of the maternal
cardiovascular system to pregnancy might be the
primary mechanism leading to placental dysfunction
[27]. Interestingly in women with pre-eclampsia, both
RV dysfunction and abnormal maternal venous
hemodynamics have been shown [30, 31]. These changes
may lead to further increased venous pressure on the
placenta which might impair trophoblast invasion result-
ing in abnormal placentation, as previously postulated
by Gyselaers et al. [32] These data support the view that
venous congestion, a typical consequence of RV dysfunc-
tion, is a critical factor in the relation between the heart
Fig. 1 Associations between cardiac function and uteroplacental circulation. a + b Regression plots between right ventricular (RV) ejection
fraction (EF), left ventricular (LV) EF and umbilical artery pulsatility index (PI) at 32 weeks of pregnancy. c + d relation between RVEF, LVEF and
normal PI vs. high PI of uterine or umbilical artery during pregnancy (at 20 or 32 weeks gestation). *Patients included with complete follow-up
data available of uterine and umbilical artery PI at 20 and 32 weeks
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and placental dysfunction. A multicenter prospective
study to investigate RV function, venous hemodynamics
and CO in pregnant women with ToF, including serial
CMR evaluation at preconception, during pregnancy and
post-partum, is currently underway to further elucidate
the pathophysiological mechanism and its clinical conse-
quence (Netherlands trial register id: NL7890). Further-
more, the pathophysiology of placental dysfunction is
most likely multifactorial and therefore studies to other
possible factors (e.g. endothelial dysfunction) are also
needed. Lastly, since non-contrast CMR is considered to
be a safe imaging modality in pregnancy for both the
mother and fetus [33], CMR could also be very useful
for evaluation of placental and foetal blood flow and de-
serves further investigation [34, 35].
Until these pathophysiological mechanisms are clari-
fied, frequent monitoring of the placental circulation
during pregnancy seems reasonable in women with
pre-existing RV dysfunction due to their higher risk
of impaired placental function and thus worse preg-
nancy outcome. If the association between venous
congestion and worse RV function would be con-
firmed in pregnant women, then it could be worth
studying the therapeutic use of medications to reduce
venous congestion, such as diuretics, on placental
circulation.
Limitations
The number of women in the present study was rela-
tively small, which limits the multivariable regression
analyses. However, with additional Lasso regression
analyses [36], the findings were confirmed which sup-
ports our findings. We acknowledge this point, but
unfortunately, rather few CMR studies in this popula-
tion are performed and we believe that despite this,
we are still able to draw some conclusions. Second,
although ZAHARA was a prospective study, CMR
data were collected retrospectively. Third, it would
have been interesting to have CMR data (of RV func-
tion and CO) at the same time as the uteroplacental
circulation measurements, but CMR studies during
pregnancy were not available in the current study.
Having said this, CMR data pre-pregnancy did correl-
ate with echocardiography data measured during
pregnancy. In addition, internal validation, using
echocardiography data for reduced RV function and
uteroplacental flow impairment correlation, showed
similar patterns. At last, not all women had complete
evaluation of uteroplacental circulation at both time
points during pregnancy (20 and 32 weeks), since
measurements could be technically difficult depending
on the location of the fetus during evaluation and
therefore missing data was unavoidable.
Conclusions
The present CMR study shows that reduced RV function
before pregnancy is associated with abnormal uteropla-
cental Doppler flow parameters. It could be postulated
that reduced RV function on pre-pregnancy CMR (≤2
years) is a predisposing factor for impaired placental
function in women with repaired ToF.
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